Home         Join Now         Sign In          Help
Products suppliers buying leads member area
    
Popular Searches:
Product > chemicals > fine & specialty chemicals > pharmaceutical chemicals > cardiovascular agents >
Page: 1 2
pravastatin sodium
EP7. 0 USP34 with GMP cert
Pravastatin sodium is an API used for lowering cholesterol a
post: zero zheng
mildronate
total impurity less than 0. 1%
Product name: mildronate Another name: mildronatum, §®§ª§­§¥§²§°§¯
post: qihechenghui
sotalol hydrochloride
best sell Sotalol hydrochloride for cardiovascular 99. 0% purity
CAS NO.: 959-24-0 Spec.:EP4 / BP2000 Usage: For cardiovas
post: hbxyh006
lisinopril intermediate 103300-91-0
Assay( HPLC ): not less than 98%
CAS:[103300-91-0] N2-[(1S)-ethoxycarbonyl-3-phenylpropyl]-
post: knpharmjenny
lisinopril intermediate 116169-90-5
Assay (HPLC): not less than 98. 5%
CAS:[ 116169-90-5 ] N2-[(1S)-ethoxycarbonyl-3-phenylpropyl
post: knpharmjenny
lisinopril intermediate 10009-20-8
Purity:> 99%
CAS:[10009-20-8] N-6-Trifluoro acetyl-L-Lysine Molecular
post: knpharmjenny
benazepril hcl-antihypertensive api
Company standard
CAS: [86541-74-4] {(3S)-3-[(1S)-1-Ethoxycarbonyl-3-phenylp
post: knpharmjenny
lisinopril-antihypertensive api
USP29, 31 , EP5. 0
CAS: [83915-83-7] (s)-1-(n2-(1-carboxy-3-phenylpropyl)-l-l
post: knpharmjenny
atorvasatin calcium
Pharmaceutical Grade
The primary uses of atorvastatin is for the treatment of dys
post: ericayang
valsartan
USP
Angiotensin II Receptor Antagonist
post: ericayang
telmisartan
USP
Angiotensin II Receptor Antagonist
post: ericayang
losartan potassium
USP
Angiotensin II Receptor antagonist
post: ericayang
irbesartan
USP
Irbesartan is a nonpeptide angiotensin II antagonist that se
post: ericayang
clonazepam
CP/ USP
Clonazepam Chinese alias: clonazepam; chlorine stability; C
post: hengshuo01
promethazine hydrochloride
BP/ USP
Promethazine hydrochloride Chinese alias: Non-Flanagan; Pul
post: hengshuo01
My Globalimporter       |      Bookmark / Share this page
Copyright (c)2003-2012 Globalimporter Inc. All Rights Reserved.